Цитування запису:

Стиль цитування APA (7-ме видання)
PA, A., O, S., YM, H., MN, S., RF, D., R, H., . . . Yunitasari. (2024). Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article. Dove Medical Press.
Чикаго стиль цитування (17-те видання)
PA, Achdiat, et al. Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article. Dove Medical Press, 2024.
Стиль цитування MLA (9-ме видання)
PA, Achdiat, et al. Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article. Dove Medical Press, 2024.
Попередження: стилі цитування не завжди правильні на всі 100%.